If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMC Markets Regulatory News (CMCX)

Share Price Information for CMC Markets (CMCX)

Share Price is delayed by 15 minutes
Get Live Data
698.00    -2.00 (-0.29%)
Bid:
690.00
Ask:
691.00
Spread: 1.00 (0.145%)
Market Cap: £1.88b
CMCX Live PriceLast checked at - London Stock Exchange

Intraday CMC Markets Share Chart

Trading Update

28 Jul 2022 07:00

RNS Number : 9869T
CMC Markets Plc
28 July 2022
 

28 July 2022

CMC Markets Plc

 

 

Trading Update - Net Operating Income in line with 2022 levels

CMC Markets Plc ("CMC" or the "Group"), a leading global provider of online ("D2C") trading and institutional ("B2B") platform technology, today issues a trading update for the period from 1 April 2022 to 27th July 2022.

Trading Update

Net operating income for the group year-to-date is in-line with levels seen in the same period in FY 2022. Active monthly trading client numbers and client assets under administration across both the leveraged and non-leveraged Australian stock broking businesses remain robust. 

The Group continues to focus on delivering a strong business performance for its financial year ending 31 March 2023. Nevertheless, the cost environment remains challenging, and the Group now expects operating costs to be in the order of 5% above guidance provided at the time of the FY 2022 results. Higher operating costs are the result of a combination of higher personnel and non-personnel costs including higher professional fees and software costs associated with expansion projects, as well as the impact of the weaker GBP (British Pound).

 

Progress towards new business growth across all platforms and geographies continues as planned and all expansion initiatives are on track.

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR. The person responsible for making this announcement is Euan Marshall, Chief Financial Officer.

 

Forward looking statements

 

This trading update may include statements that are forward looking in nature. Forward looking statements involve known and unknown risks, assumptions, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Group to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements. Except as required by the Listing Rules and applicable law, the Group undertakes no obligation to update, revise or change any forward-looking statements to reflect events or developments occurring after the date such statements are published.

 

 

Enquiries

CMC Markets Plc

James Cartwright, Investor Relations investor.relations@cmcmarkets.com

Euan Marshall, Chief Financial Officer

 

Camarco +44 (0) 20 3757 4994

Geoffrey Pelham-Lane

Jennifer Renwick

 

Notes to Editors

 

CMC Markets Plc ("CMC"), whose shares are listed on the London Stock Exchange under the ticker CMCX (LEI: 213800VB75KAZBFH5U07), was established in 1989 and is now one of the world's leading online financial trading businesses. The Group serves retail and institutional clients through regulated offices and branches in 12 countries, with a significant presence in the UK, Australia, Germany, and Singapore. CMC Markets offers an award-winning, online, and mobile trading platform, enabling clients to trade up to 10,000 financial instruments across shares, indices, foreign currencies, commodities, and treasuries through contracts for difference ("CFDs"), financial spread bets (in the UK and Ireland only) and, in Australia, access stockbroking services. More information is available at http://www.cmcmarkets.com/group/.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUBONRUAUBUAR
Date   Source Headline
9th Dec 202011:44 amRNSDirector/PDMR Shareholding
1st Dec 202012:25 pmRNSDirector/PDMR Shareholding
23rd Nov 202011:58 amRNSDirector/PDMR Shareholding
19th Nov 20207:00 amRNSInterim results
10th Nov 202010:06 amRNSDirector/PDMR Shareholding
26th Oct 20207:00 amRNSAppointment of Joint Corporate Broker
23rd Oct 20208:44 amRNSCMC welcomes ASIC consultation paper outcome
8th Oct 20207:00 amRNSTrading Update
6th Oct 20202:51 pmRNSDirector/PDMR Shareholding
22nd Sep 20204:45 pmRNSDirector/PDMR Shareholding
17th Sep 20204:19 pmRNSDirector/PDMR Shareholding
14th Sep 20209:15 amRNSIssue of Equity
9th Sep 20204:02 pmRNSDirector/PDMR Shareholding
9th Sep 20203:58 pmRNSHolding(s) in Company
3rd Sep 20207:00 amRNSTrading Update
2nd Sep 202010:40 amRNSCompliance with Listing Rule 9.2.6E
10th Aug 202011:34 amRNSDirector/PDMR Shareholding
30th Jul 20204:08 pmRNSRESULTS OF 2020 ANNUAL GENERAL MEETING
30th Jul 20201:58 pmRNSDirector/PDMR Shareholding
20th Jul 20202:14 pmRNSHolding(s) in Company
13th Jul 20207:00 amRNSAppointment of Chief Technology Officer
8th Jul 20203:41 pmRNSDirector/PDMR Shareholding
3rd Jul 20207:00 amRNSQ1 2021 Trading Update
11th Jun 20207:00 amRNSFinal results
8th Jun 20202:59 pmRNSDirector/PDMR Shareholding
7th May 20204:44 pmRNSDirector/PDMR Shareholding
8th Apr 20208:35 amRNSDirector/PDMR Shareholding
3rd Apr 20207:00 amRNSFY 2020 Pre-Close Trading Update
23rd Mar 202012:08 pmRNSSecond Price Monitoring Extn
23rd Mar 202012:02 pmRNSPrice Monitoring Extension
20th Mar 20207:00 amRNSCOVID-19 and Trading Update
12th Mar 20204:37 pmRNSPrice Monitoring Extension
9th Mar 20202:16 pmRNSDirector/PDMR Shareholding
3rd Mar 20207:00 amRNSTrading Update
7th Feb 202010:56 amRNSDirector/PDMR Shareholding
23rd Jan 20207:00 amRNSQ3 Trading Update
8th Jan 20203:20 pmRNSDirector/PDMR Shareholding
9th Dec 20192:29 pmRNSDirector/PDMR Shareholding
21st Nov 20197:00 amRNSInterim Results
7th Nov 20193:54 pmRNSDirector/PDMR Shareholding
31st Oct 20197:00 amRNSBoard Changes
15th Oct 201912:02 pmRNSPrice Monitoring Extension
9th Oct 20193:54 pmRNSDirector/PDMR Shareholding
3rd Oct 20197:00 amRNSH1 2020 Pre-Close Trading Update
17th Sep 20193:36 pmRNSDirector/PDMR Shareholding
17th Sep 20193:22 pmRNSIssue of Equity
13th Sep 20194:27 pmRNSDirector/PDMR Shareholding
9th Sep 20193:06 pmRNSDirector Declaration
30th Aug 201912:02 pmRNSNotification of transaction by PDMR's PCA
30th Aug 201911:49 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.